Where is there opportunity?
Everything we do is aimed at clarifying diagnosis and eliminating uncertainty for patients. The opportunities with genomics are endless, and we are paving the way so every patient will have the answers they seek.
Real People,
Real Science,
Real Answers.
JOHN HANNA
Chief Commercial Officer
Veracyte
This is the Age of Evidence.
Where a new definition of diagnostic truth is changing patient care as we know it. Where physicians and patients can now benefit from the evolution of healthcare and know, by design, the answers they seek.

Veracyte gives patients a clearer path for the future.

We are leading in the Age of Evidence.

LEARN MORE >
our impact
LATEST NEWS
New data published in The Lancet Respiratory Medicine show that the Envisia Genomic Classifier improves diagnosis of IPF
learn more >
LATEST NEWS
Veracyte Launches Next-Generation Percepta® Genomic Sequencing Classifier for improved lung cancer diagnosis
learn more >
WATCH
Bonnie Anderson, Veracyte CEO interview with Bill Vick/PF Warriors about the Envisia Genomic Classifier and plans to transform IPF/ILD diagnosis

WATCH NOW >


latest news
news and updates
Molecular classifier helps spot idiopathic pulmonary fibrosis
Reuters Health News
Apr 10, 2019
Finding a Way in Genomic Diagnostics: Veracyte's Bonnie Anderson on The Long Run
The Long Run with Luke Timmerman
Jan 29, 2019
Obtaining Diagnostic Test Reimbursement In The Age Of Evidence
Diagnostics World News
Jan 11, 2019